Lab-made ovarian implants to restore hormones and protect bone health in women
Official title: Sustained regulation of hypothalamus-pituitary-ovary hormones with tissue-engineered ovarian constructs as a treatment for osteoporosis in females
Funded at Miami University Oxford · NIH-11332471 · Data updated 2026-11-12
Testing whether implanting lab-grown ovarian tissue can restore hormone balance and reduce bone loss in women with menopause or ovarian failure.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Miami University Oxford NIH-funded |
| Lab location | 1 site (Oxford, United States) |
| Project start | May 15, 2023 |
| Project end | March 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $476,550 |
| NIH project number | 5R01AR081340-04 |
| Project ID | NIH-11332471 on NIH RePORTER |
Who could benefit from this research
✓Could help
Women who have lost ovarian hormone production due to menopause or surgical ovarian failure and who are at increased risk for osteoporosis are the likely candidates.
✕Less likely to help
People with a history of hormone-sensitive cancers, major cardiovascular disease, or those unwilling to consider an implant procedure may not be helped by this approach.
What this research studies
Researchers are developing tissue-engineered ovarian constructs that release natural ovarian hormones and aim to re-establish the hypothalamus‑pituitary‑ovary hormone cycle. They will test these implants in the lab and in animal models to measure sustained hormone release and effects on bone density and fracture risk. The goal is to create a long-lasting, physiologic hormone source that protects bone while using lower systemic hormone doses than traditional pills. If preclinical results are promising, the team intends to move toward studies that could include people.
Why it matters
Potential benefit: Could provide a longer-lasting, more natural hormone replacement that lowers fracture risk while avoiding some risks seen with standard hormone pills.
How similar studies have gone: Related tissue-engineering approaches have shown promise in animal studies, but human testing of ovarian implants is still largely unproven.
Where this research is happening
-
Miami University Oxford
Oxford, United States Active
Researchers
- Principal investigator: Saul, Justin — Miami University Oxford
- Study coordinator: Saul, Justin
Related research
Other NIH-funded projects on the same topics.
-
Or olive-oil derived compound to prevent bone loss in women
A safe, orally taken nutraceutical may help prevent osteoporosis in adult women by supporting bone formation and reducing bone loss.
-
When to stop, switch, or pause long-term osteoporosis medicines for older adults
This project looks at whether stopping, switching, or taking breaks from long-term osteoporosis drugs changes fracture risk and side effects for older adults.
-
Cortical Bone Mechanics Technology to better screen for osteoporosis
A new noninvasive test called CBMT uses ulnar flexural rigidity to predict fracture risk better than standard bone density tests, helping adults who may be at risk for osteoporosis.
-
Gene therapy for osteoporosis linked to ALDH2 deficiency in postmenopausal East Asian women
A gene therapy approach is being developed to reduce osteoporosis risk in postmenopausal East Asian women who have ALDH2 deficiency and drink alcohol.
-
Metabolomics clues to osteoporosis risk in diverse populations
A study using small molecules in blood samples to understand osteoporosis risk, with a focus on aging, ethnicity, and sex differences.
-
Single-Cell Study of Bone Cells to Understand Osteoporosis
Researchers will study individual bone-related cells from people to uncover why aging leads to weaker bones and higher fracture risk.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.